VR lets doctors walk in Patients' shoes to fight mental health stigma
NCT ID NCT07375199
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a short virtual reality experience can reduce stigma toward people with schizophrenia among healthcare workers and students. Participants will watch two VR videos that simulate hallucinations and paranoid thoughts, then researchers measure changes in attitudes and biases. The goal is to see if immersive perspective-taking can foster empathy and reduce discrimination in healthcare settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Virtual reality simulation of psychotic symptoms
- What this could lead to
- If it works, this could point toward a new training tool to reduce stigma and improve empathy among healthcare workers.
- What could go wrong
- This is an early-stage study with only 128 participants, and it measures attitudes rather than clinical outcomes. The effect may be small or not last long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Unité de Recherche Clinique (URC), Centre Hospitalier Henri Laborit
Poitiers, 86000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo help teens with severe mental illness?
- Blood test may spot schizophrenia early and guide treatment
- Could a broccoli compound help schizophrenia symptoms?
- Zapping the brain to ease Schizophrenia's 'Negative' symptoms?
- Could a gentle brain ZAP sharpen minds in schizophrenia?
- New schizophrenia drug shows promise in early brain study